NB
Neurocrine Biosciences Inc
🇩🇪XFRA.NB3GermanyHealthcare
€134.80EURup +1.45 (+1.09%)OpenEnd of day6:53 PM
Price€134.80+1.45 (+1.09%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US64125C1099
- CUSIP
- Not reported
Company
- Employees
- 2,500
- Headquarters
- San Diego, United States
- Website
- https://www.neurocrine.com
- CEO
- Mr. Kyle W. Gano Ph.D.
Market
- Shares outstanding
- 100.4M
- Market cap
- €13.53B
Highlights
No high and low reported for today's session.
- Market cap
- €13.53B
- EPS LTM
- $7.03calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $3.37B+34.42%up year on year
- Net income
- $705.5M+102.56%up year on year
- Gross margin
- 97.97%-0.54%down year on year
- Free cash flow
- $870.4M+64.63%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.